{"product_id":"university-of-miami-clinical-psychopharmacology-beyond-conventional-wisdom-2026","title":"University of Miami Clinical Psychopharmacology: Beyond Conventional Wisdom 2026","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper\"\u003e\r\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content wc-tab\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"details-desc\"\u003e\r\n\u003cdiv\u003e\r\n\u003ch2\u003eUniversity of Miami Clinical Psychopharmacology: Beyond Conventional Wisdom 2026\u003c\/h2\u003e\r\n\u003cdiv\u003eONly Videos no PDFs\u003c\/div\u003e\r\n\u003cdiv\u003eFeb 16 – 20, 2026\u003c\/div\u003e\r\n\u003cdiv\u003eOVERVIEW\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003eClinical Psychopharmacology: Beyond Conventional Wisdom is organized by University of Miami Miller School of Medicine Division of Continuing Medical Education and will be held from Feb 16 – 20, 2026 at The Sunny Miami Sunny Isles Beach, Curio Collection by Hilton, Sunny Isles Beach, Florida, United States of America.\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003ch2\u003eDescription:\u003c\/h2\u003e\r\n\u003cdiv\u003eThis seminar aims to enhance clinicians’ expertise in psychopharmacology by thoroughly exploring key concepts and contemporary practices. Participants will engage with a variety of conceptual models, comparing symptom-oriented and disease-oriented treatment approaches. We will critically evaluate the diagnostic validity of major psychiatric conditions and investigate evidence-based medication strategies tailored to these disorders.\u003c\/div\u003e\r\n\u003ch2\u003eCourse Description:\u003c\/h2\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eThe presentation places a strong emphasis on diagnostic accuracy and the application of research-driven clinical practices, prioritizing efficacy and safety as demonstrated in clinical trials over speculative biological mechanisms. In-depth analysis and treatment strategies will be provided for schizophrenia, bipolar disorder, depression, and anxiety disorders, with additional focus on mixed states, bipolar depression, and the nuanced role of psychopharmacology in optimizing treatment outcomes\u003c\/li\u003e\r\n \t\u003cli\u003eThe seminar will incorporate the latest research findings, including recent advancements in clinical psychopharmacology, to ensure participants are equipped with up-to-date knowledge and skills. Special attention will be given to the application of these strategies in diverse patient populations, including children, the elderly, and those with comorbid medical conditions, to promote holistic and effective patient care.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eObjectives:\u003c\/h2\u003e\r\n\u003cdiv\u003eUpon completion of this activity, participants will be able to:\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eDescribe the historical background on the major themes to be covered during the course.\u003c\/li\u003e\r\n \t\u003cli\u003eExamine the biological mechanisms of major psychotropic drug classes.\u003c\/li\u003e\r\n \t\u003cli\u003eGrasp the basic neuroanatomy relevant to clinical psychopharmacology.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize and apply key clinical trials of drug classes for various diagnoses.\u003c\/li\u003e\r\n \t\u003cli\u003eExamine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eDiscuss practices with antipsychotics, mood stabilizers, and antidepressants.\u003c\/li\u003e\r\n \t\u003cli\u003eExplain the risks and side effects of major drug classes.\u003c\/li\u003e\r\n \t\u003cli\u003eEmploy medications with an understanding of pharmacokinetic interactions.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify factors in medication use for those with comorbid medical conditions.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e\r\n\u003ctable\u003e\r\n\u003cthead\u003e\r\n\u003ctr\u003e\r\n\u003cth\u003eSr. No.\u003c\/th\u003e\r\n\u003cth\u003eTitle\u003c\/th\u003e\r\n\u003cth\u003eDuration\u003c\/th\u003e\r\n\u003cth\u003eSpeaker\u003c\/th\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/thead\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e1\u003c\/td\u003e\r\n\u003ctd\u003eBipolar Depression and Mixed States: Why Antidepressants Fail and Dopamine Blockers Work\u003c\/td\u003e\r\n\u003ctd\u003e17:22\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e2\u003c\/td\u003e\r\n\u003ctd\u003eMood Stabilizers in Bipolar Disorder: Limitations of Anticonvulsants vs Lithium\u003c\/td\u003e\r\n\u003ctd\u003e42:10\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e3\u003c\/td\u003e\r\n\u003ctd\u003eHow Mood Temperaments Drive Misdiagnosis in Psychiatry\u003c\/td\u003e\r\n\u003ctd\u003e30:02\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e4\u003c\/td\u003e\r\n\u003ctd\u003eTreating Mood Temperaments to Improve Mental Health Outcomes\u003c\/td\u003e\r\n\u003ctd\u003e21:05\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e5\u003c\/td\u003e\r\n\u003ctd\u003eAntipsychotic Safety: Neurotoxicity, Akathisia, and Tardive Dyskinesia Risks\u003c\/td\u003e\r\n\u003ctd\u003e43:58\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e6\u003c\/td\u003e\r\n\u003ctd\u003eLithium in Mood Disorders: Is It the Safest Mood Stabilizer?\u003c\/td\u003e\r\n\u003ctd\u003e56:20\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e7\u003c\/td\u003e\r\n\u003ctd\u003eLithium Safety and Renal Effects: Interpreting eGFR and True Kidney Risk\u003c\/td\u003e\r\n\u003ctd\u003e11:42\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e8\u003c\/td\u003e\r\n\u003ctd\u003eAntipsychotics in Schizophrenia: Short-Term Symptom Control vs Long-Term Outcomes\u003c\/td\u003e\r\n\u003ctd\u003e06:24\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9\u003c\/td\u003e\r\n\u003ctd\u003eAntipsychotic-Induced Akathisia and EPS: Clinical Risks and Management\u003c\/td\u003e\r\n\u003ctd\u003e20:41\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e10\u003c\/td\u003e\r\n\u003ctd\u003eAntipsychotics and Metabolic Risk: Insulin Resistance, Weight Gain, \u0026amp; More\u003c\/td\u003e\r\n\u003ctd\u003e05:54\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11\u003c\/td\u003e\r\n\u003ctd\u003eBipolar Mania Management With Antipsychotics: Acute Efficacy vs Maintenance Limitations\u003c\/td\u003e\r\n\u003ctd\u003e09:39\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12\u003c\/td\u003e\r\n\u003ctd\u003eADHD: Clinical Efficacy and Safety of Amphetamine-Based Therapies\u003c\/td\u003e\r\n\u003ctd\u003e54:33\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e13\u003c\/td\u003e\r\n\u003ctd\u003eAntidepressant Safety Risks: Suicidality, Cardiovascular Effects, and Withdrawal Syndromes\u003c\/td\u003e\r\n\u003ctd\u003e30:43\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e14\u003c\/td\u003e\r\n\u003ctd\u003eMDD Maintenance Treatment: Do Antidepressants Sustain Remission?\u003c\/td\u003e\r\n\u003ctd\u003e20:17\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e15\u003c\/td\u003e\r\n\u003ctd\u003eAcute Treatment of Major Depressive Disorder: Interpreting Effect Size, Placebo Response, and Clinical Meaningfulness\u003c\/td\u003e\r\n\u003ctd\u003e38:58\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e16\u003c\/td\u003e\r\n\u003ctd\u003eDo Antidepressants Work in Bipolar Depression or Worsen Outcomes?\u003c\/td\u003e\r\n\u003ctd\u003e18:14\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e17\u003c\/td\u003e\r\n\u003ctd\u003eBasic Concepts of Psychopharmacology for the Clinician\u003c\/td\u003e\r\n\u003ctd\u003e29:58\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e18\u003c\/td\u003e\r\n\u003ctd\u003eNeurobiology in Psychopharmacology: Why Mechanisms Matter Less Than Clinical Outcomes\u003c\/td\u003e\r\n\u003ctd\u003e12:20\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e19\u003c\/td\u003e\r\n\u003ctd\u003eAntipsychotic Psychopharmacology: Receptor Affinity, Dosing, and Adverse Effects\u003c\/td\u003e\r\n\u003ctd\u003e15:08\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e20\u003c\/td\u003e\r\n\u003ctd\u003eMood Stabilizer Neurobiology: Lithium and Antiepileptics Mechanisms\u003c\/td\u003e\r\n\u003ctd\u003e05:14\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e21\u003c\/td\u003e\r\n\u003ctd\u003ePsychopharmacology of Monoamine Agonists From Chemical Structure to Clinical Effect\u003c\/td\u003e\r\n\u003ctd\u003e16:02\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e22\u003c\/td\u003e\r\n\u003ctd\u003eBenzodiazepines \u0026amp; Alternatives for Sleep and Anxiety Disorders: Pharmacology \u0026amp; Adverse Effects\u003c\/td\u003e\r\n\u003ctd\u003e09:02\u003c\/td\u003e\r\n\u003ctd\u003eNassir Ghaemi\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":42954708353122,"sku":"MED-AMB08581","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Clinical-Psychopharmacology-Beyond-Conventional-Wisdom-2026.jpg?v=1779382867","url":"https:\/\/meducourse.com\/products\/university-of-miami-clinical-psychopharmacology-beyond-conventional-wisdom-2026","provider":"Meducourse","version":"1.0","type":"link"}